Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play

  • Sapre N
  • Selth L
N/ACitations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MicroRNAs are key regulators of gene expression and play critical roles in both normal physiology and pathology. Recent research has demonstrated that these molecules are present in body fluids, such as serum, plasma, and urine, and can be readily measured using a variety of techniques. More importantly, emerging evidence suggests that circulating or urine miRNAs are useful indicators of disease. Here, we consider the potential utility of such miRNAs as noninvasive biomarkers of prostate cancer, a disease that would benefit substantially from novel diagnostic and prognostic tools. The studies aimed at identifying diagnostic, prognostic, and/or predictive miRNAs for prostate cancer are summarised and reviewed. Finally, practical considerations that will influence the translation of this recent research into clinical implementation are discussed.

Cite

CITATION STYLE

APA

Sapre, N., & Selth, L. A. (2013). Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play. Prostate Cancer, 2013, 1–10. https://doi.org/10.1155/2013/539680

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free